[
    [
        {
            "time": "",
            "original_text": "云南白药首季业绩降四成 怪小米和伊利股价不给力？ 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "首季业绩",
                    "下降",
                    "小米",
                    "伊利",
                    "股价",
                    "盈利能力"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药首季业绩降四成 怪小米和伊利股价不给力？ 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]